Normoglycemic individuals | Diabetic individuals | |||||
---|---|---|---|---|---|---|
Without CAD | With DAC | p** | Without CAD | With CAD | p** | |
N | 40 | 54 | 110 | 237 | ||
Age (years) | 55.8 (12.9) | 60.2 (13.6) | NS | 59.1 (10.2) | 61.6 (9.8) | 0.03 |
Male gender (%) | 53.7 | 76.4 | 0.02 | 40 | 61.2 | 0.001 |
BMI (kg/m2) | 27.1 (5.24) | 26.4 (4.91) | NS | 29.2 (5.32) | 28.0 (4.40) | 0.04 |
Abdominal circumference (cm) | 95.5 (12.9) | 97.0 (12.4) | NS | 101.9 (12.65) | 100.5 (12.00) | NS |
Diabetes duration (years)* | – | – | – | 4 [1-10] | 6 [2-10] | NS |
SBP (mmHg) | 134.4 (21.8) | 131.9 (22.6) | NS | 145.2 (24.6) | 142.3 (24.6) | NS |
DBP (mmHg) | 79.0 (15.4) | 79.7 (14.2) | NS | 82.4 (16.1) | 79.2 (12.1) | NS |
FPG (mg/dl) | 90.4 (6.8) | 90.8 (7.1) | NS | 143.4 (48.9) | 162.3 (69.8) | 0.004 |
Fasting insulin (mU/L) | 6.44 (4.38) | 6.10 (4.77) | NS | 14.6 (17.6) | 10.9 (8.91) | NS |
HOMA2B | 69.17 (25.63) | 66.50 (25.82) | NS | 75.56 (51.83) | 64.07 (48.51) | NS |
HOMA2-IR | 0.70 (0.41) | 0.66 (0.42) | NS | 1.84 (1.67) | 1.54 (1.03) | NS |
HbA1c (%) | 5.28 (0.27) | 5.35 (0.25) | NS | 7.59 (1.55) | 8.03 (1.91) | 0.03 |
LDL (mg/dL) | 105.0 (34.8) | 98.6 (33.4) | NS | 101.0 (39.9) | 98.1 (36.2) | NS |
HDL (mg/dL) | 42.7 (11.4) | 38.4 (10.340 | NS | 44.4 (15.9) | 39.2 (13.2) | 0.003 |
Triglycerides (mg/dL)* | 116.0 [75.25-158.0] | 115.0 [93.0-158.0] | NS | 121.0 [78.5-184.25] | 140.0 [106.0-204.0] | 0.002 |
Total Adiponectin (μg/mL)* | 11.80 [6.85-18.62] | 8.73 [5.95-14.88] | NS | 8.26 [5.49-12.86] | 7.36 [5.33-11.83] | NS |
eGFR (mL/min) | 88.1 (22.3) | 83.6 (21.4) | NS | 83.1 (28.3) | 80.4 (24.2) | NS |
Hypertension (%) | 73.2 | 72.7 | NS | 95.5 | 94.5 | NS |
Framingham risk above 20% (%) | 8.6 | 17 | NS | 21.6 | 32.5 | 0.047 |
Statin use (%) | 41.5 | 56.4 | NS | 60.9 | 72.6 | 0.03 |
Aspirin use (%) | 58.5 | 67.3 | NS | 70 | 79.7 | 0.046 |
Diabetes treatment | ||||||
Insulin (%) | – | – | – | 24.5 | 28.3 | NS |
Sulphonylurea (%) | – | – | – | 20.4 | 27 | NS |
Metformin (%) | – | – | – | 44.5 | 45.6 | NS |
Dyslipidemia (%) | 70.7 | 89.1 | 0.023 | 89.1 | 90.3 | NS |
Familial history of CAD (%) | 29.3 | 45.5 | NS | 34.9 | 35 | NS |